Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linezolid vs vancomycin for MRSA nosocomial pneumonia
2004-000827-13Phase 4Completed
- Sponsor
- Pfizer
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of linezolid in hospital-acquired pneumonia (HAP) and Staphylococcus aureus infection (2 arms), sponsored by Pfizer. Primary endpoints: Clinical response at end of treatment, Clinical response at end of study and 3 more. Started Feb 2005; status: completed.
02
Drugs
linezolid
03
Conditions
hospital-acquired pneumonia (HAP)Staphylococcus aureus infection
Beyond the preview
Go deeper on 2004-000827-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000827-13.